Keywords: daiichi, book, 8b, loss, ranbaxy, buy, japanese
Daiichi to book a $3.8B loss on Ranbaxy buy
Article | 12 January 2009
Japanese drugmaker Daiichi Sankyo plans to record a valuation loss and one-time write-down of goodwill on its investment in Indian ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
